Editas Medicine (EDIT)
(Real Time Quote from BATS)
$3.74 USD
-0.17 (-4.35%)
Updated Sep 20, 2024 12:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
Editas Medicine, Inc. [EDIT]
Reports for Purchase
Showing records 1 - 20 ( 105 total )
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for EDIT 112123
Provider: Stock Traders Daily
Analyst: Research Department